Lixte Biotechnology Holdings Inc (LIXT) — Cash Flow-to-Debt Ratio
Lixte Biotechnology Holdings Inc (LIXT) has a Cash Flow-to-Debt Ratio of -0.61x as of December 2025, meaning its operating cash flow of $-1.09 Million could theoretically repay -1% of its total liabilities ($1.77 Million) in one year. Check how high is Lixte Biotechnology Holdings Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Lixte Biotechnology Holdings Inc Cash Flow-to-Debt Ratio (2005–2025)
Historical debt coverage capacity for Lixte Biotechnology Holdings Inc across 21 annual periods. Also explore how large is Lixte Biotechnology Holdings Inc's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Lixte Biotechnology Holdings Inc (2005–2025)
Year-by-year debt coverage analysis for Lixte Biotechnology Holdings Inc. For market capitalisation and broader financial context, see how much is Lixte Biotechnology Holdings Inc worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.73x | $-3.07 Million | $1.77 Million | ▲ +82.6% |
| 2024 | -9.94x | $-3.16 Million | $318.28K | ▲ +27.3% |
| 2023 | -13.68x | $-4.29 Million | $313.86K | ▼ -17.1% |
| 2022 | -11.68x | $-4.61 Million | $394.79K | ▲ +14.6% |
| 2021 | -13.68x | $-4.14 Million | $302.93K | ▼ -38.9% |
| 2020 | -9.84x | $-2.13 Million | $216.52K | ▼ -39.9% |
| 2019 | -7.04x | $-1.67 Million | $237.90K | ▲ +1.8% |
| 2018 | -7.16x | $-1.51 Million | $210.91K | ▼ -89.2% |
| 2017 | -3.79x | $-1.41 Million | $373.02K | ▲ +50.7% |
| 2016 | -7.67x | $-1.68 Million | $218.65K | ▼ -0.5% |
| 2015 | -7.64x | $-2.18 Million | $285.64K | ▼ -27.7% |
| 2014 | -5.98x | $-1.64 Million | $273.44K | ▼ -63.1% |
| 2013 | -3.67x | $-1.18 Million | $321.77K | ▲ +20.6% |
| 2012 | -4.62x | $-1.21 Million | $261.15K | ▼ -19.1% |
| 2011 | -3.88x | $-1.36 Million | $350.75K | ▲ +19.2% |
| 2010 | -4.80x | $-936.39K | $195.06K | ▼ -125.8% |
| 2009 | -2.13x | $-638.44K | $300.26K | ▼ -33.5% |
| 2008 | -1.59x | $-597.69K | $375.20K | ▲ +42.8% |
| 2007 | -2.79x | $-702.87K | $252.18K | ▲ +21.7% |
| 2006 | -3.56x | $-443.45K | $124.50K | ▼ -35.5% |
| 2005 | -2.63x | $-32.87K | $12.50K | — |